Search our Innovation Portfolio

Neotherix is an SME dedicated to developing solutions for problem wounds based on electrospun scaffolds. This project explores the feasibility of developing a novel device for recto-vaginal fistula treatment. Building on work conducted in fistula-in-ano, in collaboration with University of Birmingham, University Hospitals Birmingham NHS Trust, and SME Keighleycolo Ltd, the postulated device integrates a drainage seton with a bioresorbable scaffold to promote more effective drainage and repair. It aims to reduce the need for multiple surgeries and hospital admissions, improving patient outcomes with a less invasive approach.

Nettle, is a Class-IIa, CE-marked, drug-free, hormone-free, Bluetooth-controlled wearable transcranial direct current stimulation (tDCS) device developed by women at Samphire Neuroscience, and is tailored to women’s needs. Nettle provides non-invasive stimulation to both the motor cortex (to alleviate physical pain) and the prefrontal cortex (to improve symptoms of mood disorders). Use of Nettle during the final two weeks of the menstrual cycle has been shown to relieve pain and low mood associated with dysmenorrhea (painful menstrual cramps), premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD).

Women are 50% more likely than men to be misdiagnosed or diagnosed late and 35% less likely to receive life-saving treatment. LightHearted AI has developed LightScope, a breakthrough technology that can reduce the heart valve disease (HVD) diagnosis gap.

LightScope uses laser light to captures heart sounds, ECG and Blood Pressure contactlessly in one single scan. AI algorithms analyse this data to diagnose several conditions, including HVD. LightScope is accurate (>90% accuracy for HVD), requires no training and is cost-effective, addressing underdiagnosis and late diagnosis issues.